US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 13.810
- +0.560+4.23%
Close Apr 26 16:00 ET
- 13.710
- -0.100-0.72%
Post 17:41 ET
15.64BMarket Cap-27620P/E (TTM)
13.980High13.310Low10.28MVolume13.310Open13.250Pre Close141.06MTurnover0.91%Turnover RatioLossP/E (Static)1.13BShares14.46552wk High2.08P/B15.55BFloat Cap7.08552wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM5.06%Amplitude3.107Historical Low13.723Avg Price1Lot Size
Teva Pharmaceutical Industries Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -13.96%1.37B | 21.69%1.18B | -99.08%5M | 163.41%324M | -195.92%-145M | 99.25%1.59B | 113.38%973M | 2.65%543M | -43.58%123M | 87.90%-49M |
| Net income from continuing operations | 75.39%-615M | 132.15%433M | 51.72%88M | -246.72%-898M | 75.00%-238M | -648.03%-2.5B | -786.18%-1.35B | -80.79%58M | -216.67%-259M | -1,233.33%-952M |
| Operating gains losses | -510.00%-41M | -211.11%-10M | -138.46%-5M | -372.73%-30M | 117.39%4M | -90.38%10M | 280.00%9M | -18.75%13M | -42.11%11M | -131.08%-23M |
| Depreciation and amortization | -11.85%1.15B | -13.07%266M | -11.84%283M | -16.20%300M | -5.88%304M | -1.65%1.31B | -4.38%306M | -2.43%321M | 17.38%358M | -14.10%323M |
| Deferred tax | 70.21%-317M | -78.67%32M | -552.27%-199M | 95.94%-44M | 39.43%-106M | -786.67%-1.06B | 212.78%150M | 450.00%44M | -6,868.75%-1.08B | -1,490.91%-175M |
| Other non cash items | 167.03%61M | 57.69%41M | 92.50%-3M | 88.79%-12M | 13.33%34M | -450.00%-91M | -13.33%26M | -1,433.33%-40M | -3,666.67%-107M | 400.00%30M |
| Change In working capital | -105.31%-72M | -6.32%326M | -355.91%-238M | -42.37%204M | -165.12%-364M | 179.66%1.36B | 93.33%348M | 146.04%93M | 158.71%354M | 151.95%559M |
| -Change in receivables | -96.41%12M | ---- | ---- | ---- | ---- | 158.19%334M | ---- | ---- | ---- | ---- |
| -Change in inventory | 9.82%-147M | ---- | ---- | ---- | ---- | -142.89%-163M | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | -21.07%1.59B | ---- | ---- | ---- | ---- | 163.35%2.01B | ---- | ---- | ---- | ---- |
| -Change in other current assets | -84.18%-1.53B | ---- | ---- | ---- | ---- | 63.54%-828M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -13.96%1.37B | 21.69%1.18B | -99.08%5M | 163.41%324M | -195.92%-145M | 99.25%1.59B | 113.38%973M | 2.65%543M | -43.58%123M | 87.90%-49M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 47.56%968M | 79.17%301M | 25.17%184M | 68.72%302M | 12.42%181M | -56.93%656M | -31.71%168M | -48.96%147M | -62.79%179M | -68.31%161M |
| Net PPE purchase and sale | 4.01%-526M | 16.20%-119M | -22.13%-149M | 6.30%-119M | -3.79%-137M | 2.49%-548M | 7.19%-142M | 69.50%-122M | -4,333.33%-127M | -1,000.00%-132M |
| Net business purchase and sale | 11.48%68M | --0 | 400.00%10M | 211.11%56M | --0 | -80.39%61M | -45.24%23M | -99.26%2M | --18M | ---7M |
| Net investment purchase and sale | -1,633.33%-46M | -140.00%-2M | -2,000.00%-38M | -166.67%-2M | 0.00%-4M | -97.60%3M | 145.45%5M | -89.47%2M | -95.89%3M | -109.09%-4M |
| Net other investing changes | ---5M | --1M | -133.33%-1M | -100.00%-4M | 0.00%-1M | ---- | ---- | --3M | ---2M | ---1M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 47.56%968M | 79.17%301M | 25.17%184M | 68.72%302M | 12.42%181M | -56.93%656M | -31.71%168M | -48.96%147M | -62.79%179M | -68.31%161M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -28.65%-1.91B | 18.99%-576M | -30.91%-576M | 83.73%-55M | -35,400.00%-706M | 31.54%-1.49B | -41.92%-711M | 62.62%-440M | -33,700.00%-338M | 100.41%2M |
| Net issuance payments of debt | -24.25%-1.7B | 29.38%-500M | -36.99%-500M | --0 | ---701M | 36.80%-1.37B | -41.60%-708M | 68.94%-365M | ---296M | --0 |
| Net other financing activities | -79.66%-212M | -2,433.33%-76M | -2.70%-76M | -30.95%-55M | -350.00%-5M | -1,866.67%-118M | -200.00%-3M | -3,600.00%-74M | -4,100.00%-42M | 200.00%2M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -28.65%-1.91B | 18.99%-576M | -31.21%-576M | 83.73%-55M | -35,400.00%-706M | 31.54%-1.49B | -41.92%-711M | 62.70%-439M | -33,700.00%-338M | 100.41%2M |
| Net cash flow | ||||||||||
| Beginning cash position | 28.94%2.83B | -0.35%2.25B | 27.69%2.67B | -3.29%2.18B | 28.94%2.83B | 0.96%2.2B | 10.42%2.26B | -14.16%2.09B | 29.09%2.25B | 0.96%2.2B |
| Current changes in cash | -44.27%423M | 111.40%909M | -254.18%-387M | 1,686.11%571M | -687.72%-670M | 409.40%759M | 113.93%430M | 169.72%251M | -105.16%-36M | 129.23%114M |
| Effect of exchange rate changes | 75.61%-30M | -53.42%68M | 60.71%-33M | 37.40%-77M | 119.35%12M | 3.91%-123M | 404.17%146M | -170.97%-84M | -2,360.00%-123M | -40.91%-62M |
| End cash Position | 13.87%3.23B | 13.87%3.23B | -0.35%2.25B | 27.69%2.67B | -3.29%2.18B | 28.94%2.83B | 28.94%2.83B | 10.42%2.26B | -14.16%2.09B | 29.09%2.25B |
| Free cash flow | -19.19%842M | 28.16%1.07B | -134.20%-144M | 5,225.00%205M | -37.86%-284M | 341.53%1.04B | 174.26%831M | 9.92%421M | -103.81%-4M | 62.88%-206M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg